Physician profile
Afshin Razi
NPI 1730142522
$3,204.38
in general payments reported to CMS, 2019-2025
16 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $129 · 2021: $140 · 2023: $185 · 2024: $864 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,218.36 | 2019 | |
| Medtronic, INC. | $357.72 | 2024 | Prestige LP Cervical Disc System |
| Amgen INC. | $298.73 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $232.27 | 2019-2020 | |
| Saluda Medical Americas, INC. | $192.69 | 2023-2024 | Evoke, Evoke Scs |
| Icotec Medical INC. | $171.12 | 2024 | Vader Pedicle System |
| Next Science LLC | $140.43 | 2021 | |
| Baxter Healthcare | $127.71 | 2019-2025 | Floseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.94 | 2023 | Cycloset |
| Si-Bone, INC. | $100.60 | 2019 | |
| Stryker Corporation | $80.66 | 2019 | |
| Depuy Synthes Sales INC. | $79.25 | 2024 | Symphony |
| Endo Pharmaceuticals INC. | $24.96 | 2019 | |
| Polynovo North America LLC | $21.54 | 2024 | Novosorb Btm |
| Biocomposites INC | $20.19 | 2025 | Stimulan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $13.21 | 2025 | Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afshin Razi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.